Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.

Source:http://linkedlifedata.com/resource/pubmed/id/18973288

J. Med. Chem. 2008 Nov 27 51 22 7161-8

Download in:

View as

Triples

General Info

PMID
18973288